Hydrogel formulations containing non-ionic polymers for topical delivery of bacteriophages.
暂无分享,去创建一个
[1] Yannan Liu,et al. Development of Thermosensitive Hydrogel Wound Dressing Containing Acinetobacter baumannii Phage against Wound Infections. , 2021, International journal of pharmaceutics.
[2] H. Chan,et al. Bacteriophage-Delivering Hydrogels: Current Progress in Combating Antibiotic Resistant Bacterial Infection , 2021, Antibiotics.
[3] Jian Li,et al. Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice , 2020, Antimicrobial Agents and Chemotherapy.
[4] H. Chan,et al. Topical application of bacteriophages for treatment of wound infections. , 2020, Translational research : the journal of laboratory and clinical medicine.
[5] M. H. Fernandes,et al. Encapsulated bacteriophages in alginate-nanohydroxyapatite hydrogel as a novel delivery system to prevent orthopedic implant-associated infections. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[6] S. Chhibber,et al. A novel wound dressing consisting of PVA-SA hybrid hydrogel membrane for topical delivery of bacteriophages and antibiotics. , 2019, International journal of pharmaceutics.
[7] Christopher T. Johnson,et al. Bacteriophage Delivering Hydrogels Reduce Biofilm Formation In Vitro and Infection In Vivo. , 2019, Journal of biomedical materials research. Part A.
[8] A. Shukla,et al. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. , 2019, Signal transduction and targeted therapy.
[9] E. Kutter,et al. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients , 2019, The AAPS Journal.
[10] H. Chan,et al. Phage therapy for respiratory infections , 2018, Advanced drug delivery reviews.
[11] B. Blasdel,et al. Compassionate Use of Bacteriophage Therapy for Foot Ulcer Treatment as an Effective Step for Moving Toward Clinical Trials. , 2018, Methods in molecular biology.
[12] M. Elmazar,et al. Honey-based hydrogel: In vitro and comparative In vivo evaluation for burn wound healing , 2017, Scientific Reports.
[13] M. Vaneechoutte,et al. Stability of bacteriophages in burn wound care products , 2017, PloS one.
[14] M. Reddy,et al. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections , 2017, PloS one.
[15] L. Applegate,et al. Effect of Human Burn Wound Exudate on Pseudomonas aeruginosa Virulence , 2016, mSphere.
[16] B. Blasdel,et al. Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. , 2016, Journal of Wound Care.
[17] Serge Morand,et al. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..
[18] K. Rumbaugh,et al. Requirements for Pseudomonas aeruginosa Acute Burn and Chronic Surgical Wound Infection , 2014, PLoS genetics.
[19] A. S. Veiga,et al. Antimicrobial hydrogels for the treatment of infection. , 2013, Biopolymers.
[20] Shuai Le,et al. Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas aeruginosa Bacteriophages PaP1 and JG004 , 2013, PloS one.
[21] A. Górski,et al. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[22] M. Falagas,et al. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? , 2013, The Journal of infection.
[23] S. Agnew,et al. Bacteriophage Therapy for Staphylococcus aureus Biofilm–Infected Wounds: A New Approach to Chronic Wound Care , 2013, Plastic and reconstructive surgery.
[24] R. Pelton,et al. Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in Meat by Using Phages Immobilized on Modified Cellulose Membranes , 2011, Applied and Environmental Microbiology.
[25] S. Chhibber,et al. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. , 2010, Journal of infection in developing countries.
[26] A. Hidrón,et al. Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008 , 2010, Infection Control & Hospital Epidemiology.
[27] D. Herndon,et al. Emerging infections in burns. , 2009, Surgical infections.
[28] E. Lingohr,et al. Enumeration of bacteriophages using the small drop plaque assay system. , 2009, Methods in molecular biology.
[29] L. Rice. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.
[30] J. Fralick,et al. Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model , 2007, Antimicrobial Agents and Chemotherapy.
[31] A. Metters,et al. Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.
[32] M. Falagas,et al. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.
[33] K. Poole. Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.
[34] S. Baumgartner,et al. Network Structure of Cellulose Ethers Used in Pharmaceutical Applications During Swelling and at Equilibrium , 2004, Pharmaceutical Research.
[35] P. Tulkens,et al. Aminoglycosides: Nephrotoxicity , 1999, Antimicrobial Agents and Chemotherapy.
[36] B. Amsden,et al. Solute Diffusion within Hydrogels. Mechanisms and Models , 1998 .